620 related articles for article (PubMed ID: 23664896)
1. Profile of pediatric Crohn's disease in Belgium.
De Greef E; Mahachie John JM; Hoffman I; Smets F; Van Biervliet S; Scaillon M; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; Peeters H; Baert F; D'Haens G; Rahier JF; Etienne I; Bauraind O; Van Gossum A; Vermeire S; Fontaine F; Muls V; Louis E; Van de Mierop F; Coche JC; Van Steen K; Veereman G; ;
J Crohns Colitis; 2013 Dec; 7(11):e588-98. PubMed ID: 23664896
[TBL] [Abstract][Full Text] [Related]
2. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
[TBL] [Abstract][Full Text] [Related]
3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
4. Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up.
De Greef E; Hoffman I; Smets F; Van Biervliet S; Bontems P; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; De Vos M; Baert F; Bossuyt P; Rahier JF; Franchimont D; Vermeire S; Fontaine F; Louis E; Coche JC; Veereman G;
J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):253-8. PubMed ID: 26835906
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
6. The course of anaemia in children and adolescents with Crohn's disease included in a prospective registry.
Van Biervliet S; Smets F; Hofmann I; Degreef E; Hauser B; Bontems P; Vande Velde S; Arts W; Paquot I; Alliet P; Bossuyt P; Louis E; Baert F; Bauraind O; Rahier JF; Veereman G
Int J Colorectal Dis; 2015 Jan; 30(1):51-6. PubMed ID: 25354967
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry.
Buderus S; Scholz D; Behrens R; Classen M; De Laffolie J; Keller KM; Zimmer KP; Koletzko S;
Dtsch Arztebl Int; 2015 Feb; 112(8):121-7. PubMed ID: 25759978
[TBL] [Abstract][Full Text] [Related]
8. Paediatric inflammatory bowel disease in New Zealand.
Yap J; Wesley A; Mouat S; Chin S
N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of new-onset Crohn's disease in children and adolescents in dependency of age, initial location, initial severity level and therapy over the period 2000-2014 based on the Saxon Pediatric IBD-Registry in Germany.
Dong F; Kern I; Weidner J; Kügler K; Rothe U; Amin M; Laaß MW; Flemming G; Winkler U; Richter T; Kugler J; Manuwald U
PLoS One; 2023; 18(6):e0287860. PubMed ID: 37384664
[TBL] [Abstract][Full Text] [Related]
10. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.
Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A;
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003.
Vijverman A; Piront P; Belaiche J; Louis E
Acta Gastroenterol Belg; 2006; 69(1):1-4. PubMed ID: 16673554
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO).
Wauters L; Smets F; De Greef E; Bontems P; Hoffman I; Hauser B; Alliet P; Arts W; Peeters H; Van Biervliet S; Paquot I; Van de Vijver E; De Vos M; Bossuyt P; Rahier JF; Dewit O; Moreels T; Franchimont D; Muls V; Fontaine F; Louis E; Coche JC; Baert F; Paul J; Vermeire S; Veereman G
Inflamm Bowel Dis; 2017 Sep; 23(9):1584-1591. PubMed ID: 28696956
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of frequency, clinical course and treatment of Crohn's disease based upon the own material and experience].
Czkwianianc E; Kolasa-Kicińska M; Trojanowska-Lipczyk J; Makosiej R; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):446-51. PubMed ID: 19606694
[TBL] [Abstract][Full Text] [Related]
14. Sex-specific risks for pediatric onset among patients with Crohn's disease.
Montgomery SM; Wakefield AJ; Ekbom A
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):303-9. PubMed ID: 15017672
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
[TBL] [Abstract][Full Text] [Related]
16. Natural history of children with mild Crohn's disease.
Sharma Y; Bousvaros A; Liu E; Bender Stern J
World J Gastroenterol; 2019 Aug; 25(30):4235-4245. PubMed ID: 31435176
[TBL] [Abstract][Full Text] [Related]
17. Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease.
Müller KE; Lakatos PL; Kovacs JB; Arato A; Varkonyi A; Nemes E; Tarnok A; Toth G; Papp M; Solyom E; Horvath A; Guthy I; Kovacs M; Veres G;
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):50-5. PubMed ID: 26192700
[TBL] [Abstract][Full Text] [Related]
18. Predictors of immunomodulator use as early therapy in pediatric Crohn's disease.
Jacobstein DA; Mamula P; Markowitz JE; Leonard M; Baldassano RN
J Clin Gastroenterol; 2006 Feb; 40(2):145-8. PubMed ID: 16394876
[TBL] [Abstract][Full Text] [Related]
19. Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.
Szabó D; Kökönyei G; Arató A; Dezsőfi A; Molnár K; Müller KE; Lakatos PL; Papp M; Lovász BD; Golovics PA; Cseh A; Veres G
J Crohns Colitis; 2014 Aug; 8(8):747-55. PubMed ID: 24434181
[TBL] [Abstract][Full Text] [Related]
20. [Frequency and characteristics of granulomas in 368 pediatric patients with Crohn's disease].
Müller KE; Lakatos PL; Papp M; Veres G
Orv Hetil; 2013 Oct; 154(43):1702-8. PubMed ID: 24140509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
